Gainers & Losers
Fri Mar 13 2026 10:10:14- Hindustan Unilever share price
- ₹2,160.551.18%
- Bharti Airtel share price
- ₹1,806.700.33%
Active Stocks
Fri Mar 13 2026 10:25:25- Yes Bank share price
- ₹18.81-2.59%
- Suzlon Energy share price
- ₹41.40-2.50%
- Tata Motors Passenger Vehi...
- ₹314.30-3.13%
- Eternal share price
- ₹216.00-2.37%
- Adani Power share price
- ₹146.70-1.61%
Business News/Market/Market Stats/Eris Lifesciences share price/ Eris Lifesciences Profit Loss Annual
Eris Lifesciences Profit & Loss Annual
1,316.65 -34.35 (-2.54%)Updated : 13 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 2,190.96 | 1,514.78 | 1,263.49 | 922.54 |
| Other Net | 9.21 | 5.57 | 1.72 | 3.39 |
| Diluted Weighted Average Shares | 13.63 | 13.62 | 13.62 | 13.59 |
| Gain( Loss)on Saleof Assets | -0.92 | -2.14 | -2.01 | -4.25 |
| Depreciation/ Amortization | 315.46 | 182.61 | 117.09 | 64.71 |
| Operating Income | 702.68 | 494.37 | 421.66 | 424.50 |
| Net Income | 351.84 | 391.98 | 382.16 | 406.11 |
| Income Availableto Com Excl Extra Ord | 351.84 | 391.98 | 382.16 | 406.11 |
| Other Operating Expenses Total | 20.18 | 22.09 | 26.92 | 23.70 |
| Net Income Before Taxes | 488.87 | 431.24 | 404.64 | 442.20 |
| Minority Interest | -22.83 | -5.07 | 8.00 | 0.32 |
| Net Income After Taxes | 374.67 | 397.05 | 374.16 | 405.79 |
| Income Availableto Com Incl Extra Ord | 351.84 | 391.98 | 382.16 | 406.11 |
| Costof Revenue Total | 754.31 | 402.97 | 365.90 | 266.33 |
| Gross Profit | 2,139.33 | 1,606.18 | 1,319.25 | 1,080.72 |
| Interest Inc( Exp) Net- Non- Op Total | -222.10 | -66.56 | -16.74 | 18.56 |
| Unusual Expense( Income) | -0.02 | - | 0.00 | - |
| Diluted Net Income | 351.84 | 391.98 | 382.16 | 406.11 |
| Provisionfor Income Taxes | 114.20 | 34.19 | 30.48 | 36.41 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 351.84 | 391.98 | 382.16 | 406.11 |
| Total Revenue | 2,893.64 | 2,009.14 | 1,685.15 | 1,347.04 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,893.64 | 2,009.14 | 1,685.15 | 1,347.04 |
| Selling/ General/ Admin Expenses Total | 1,098.59 | 901.39 | 747.48 | 535.07 |
| Diluted Normalized EPS | 25.87 | 28.93 | 28.20 | 30.17 |
| Research Development | 2.44 | 5.72 | 6.10 | 32.74 |
| Diluted EPS Excluding Extra Ord Items | 25.81 | 28.79 | 28.07 | 29.88 |
| DPS- Common Stock Primary Issue | - | 0.00 | 7.35 | 6.01 |
*All figures in crores except per share values
Eris Lifesciences Quick Links
Eris Lifesciences Dividend Eris Lifesciences Bonus Eris Lifesciences News Eris Lifesciences AGM Eris Lifesciences Rights Eris Lifesciences Splits Eris Lifesciences Board Meetings Eris Lifesciences Key Metrics Eris Lifesciences Shareholdings Eris Lifesciences Balance Sheet Eris Lifesciences Cashflow Eris Lifesciences Q1 Results Eris Lifesciences Q2 Results Eris Lifesciences Q3 Results Eris Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,184.40+48.95(2.29%)
3,568.35+36.20(1.02%)
1,814.30+13.50(0.75%)
3,575.85-145.10 (-3.90%)
186.35-7.10 (-3.67%)